Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.

Hydrogen sulfide (H2S) is a mediator with demonstrated protective effects for the cardiovascular system. On the other hand, prostaglandin (PG)E2 is involved in vascular wall remodeling by regulating matrix metalloproteinase (MMP) activities. We tested the hypothesis that endogenous H2S may modulate...

Full description

Bibliographic Details
Main Authors: Ingrid Gomez, Gulsev Ozen, Catherine Deschildre, Yasmine Amgoud, Lilia Boubaya, Isabelle Gorenne, Chabha Benyahia, Thomas Roger, Guy Lesèche, Erwan Galardon, Gokce Topal, Marie-Paule Jacob, Dan Longrois, Xavier Norel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4928935?pdf=render
id doaj-80fadfc49ee9481fab4fad5570973d93
record_format Article
spelling doaj-80fadfc49ee9481fab4fad5570973d932020-11-24T20:45:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015842110.1371/journal.pone.0158421Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.Ingrid GomezGulsev OzenCatherine DeschildreYasmine AmgoudLilia BoubayaIsabelle GorenneChabha BenyahiaThomas RogerGuy LesècheErwan GalardonGokce TopalMarie-Paule JacobDan LongroisXavier NorelHydrogen sulfide (H2S) is a mediator with demonstrated protective effects for the cardiovascular system. On the other hand, prostaglandin (PG)E2 is involved in vascular wall remodeling by regulating matrix metalloproteinase (MMP) activities. We tested the hypothesis that endogenous H2S may modulate PGE2, MMP-1 activity and endogenous tissue inhibitors of MMPs (TIMP-1/-2). This regulatory pathway could be involved in thinning of abdominal aortic aneurysm (AAA) and thickening of saphenous vein (SV) varicosities. The expression of the enzyme responsible for H2S synthesis, cystathionine-γ-lyase (CSE) and its activity, were significantly higher in varicose vein as compared to SV. On the contrary, the endogenous H2S level and CSE expression were lower in AAA as compared to healthy aorta (HA). Endogenous H2S was responsible for inhibition of PGE2 synthesis mostly in varicose veins and HA. A similar effect was observed with exogenous H2S and consequently decreasing active MMP-1/TIMP ratios in SV and varicose veins. In contrast, in AAA, higher levels of PGE2 and active MMP-1/TIMP ratios were found versus HA. These findings suggest that differences in H2S content in AAA and varicose veins modulate endogenous PGE2 production and consequently the MMP/TIMP ratio. This mechanism may be crucial in vascular wall remodeling observed in different vascular pathologies (aneurysm, varicosities, atherosclerosis and pulmonary hypertension).http://europepmc.org/articles/PMC4928935?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ingrid Gomez
Gulsev Ozen
Catherine Deschildre
Yasmine Amgoud
Lilia Boubaya
Isabelle Gorenne
Chabha Benyahia
Thomas Roger
Guy Lesèche
Erwan Galardon
Gokce Topal
Marie-Paule Jacob
Dan Longrois
Xavier Norel
spellingShingle Ingrid Gomez
Gulsev Ozen
Catherine Deschildre
Yasmine Amgoud
Lilia Boubaya
Isabelle Gorenne
Chabha Benyahia
Thomas Roger
Guy Lesèche
Erwan Galardon
Gokce Topal
Marie-Paule Jacob
Dan Longrois
Xavier Norel
Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.
PLoS ONE
author_facet Ingrid Gomez
Gulsev Ozen
Catherine Deschildre
Yasmine Amgoud
Lilia Boubaya
Isabelle Gorenne
Chabha Benyahia
Thomas Roger
Guy Lesèche
Erwan Galardon
Gokce Topal
Marie-Paule Jacob
Dan Longrois
Xavier Norel
author_sort Ingrid Gomez
title Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.
title_short Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.
title_full Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.
title_fullStr Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.
title_full_unstemmed Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.
title_sort reverse regulatory pathway (h2s / pge2 / mmp) in human aortic aneurysm and saphenous vein varicosity.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description Hydrogen sulfide (H2S) is a mediator with demonstrated protective effects for the cardiovascular system. On the other hand, prostaglandin (PG)E2 is involved in vascular wall remodeling by regulating matrix metalloproteinase (MMP) activities. We tested the hypothesis that endogenous H2S may modulate PGE2, MMP-1 activity and endogenous tissue inhibitors of MMPs (TIMP-1/-2). This regulatory pathway could be involved in thinning of abdominal aortic aneurysm (AAA) and thickening of saphenous vein (SV) varicosities. The expression of the enzyme responsible for H2S synthesis, cystathionine-γ-lyase (CSE) and its activity, were significantly higher in varicose vein as compared to SV. On the contrary, the endogenous H2S level and CSE expression were lower in AAA as compared to healthy aorta (HA). Endogenous H2S was responsible for inhibition of PGE2 synthesis mostly in varicose veins and HA. A similar effect was observed with exogenous H2S and consequently decreasing active MMP-1/TIMP ratios in SV and varicose veins. In contrast, in AAA, higher levels of PGE2 and active MMP-1/TIMP ratios were found versus HA. These findings suggest that differences in H2S content in AAA and varicose veins modulate endogenous PGE2 production and consequently the MMP/TIMP ratio. This mechanism may be crucial in vascular wall remodeling observed in different vascular pathologies (aneurysm, varicosities, atherosclerosis and pulmonary hypertension).
url http://europepmc.org/articles/PMC4928935?pdf=render
work_keys_str_mv AT ingridgomez reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT gulsevozen reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT catherinedeschildre reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT yasmineamgoud reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT liliaboubaya reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT isabellegorenne reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT chabhabenyahia reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT thomasroger reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT guyleseche reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT erwangalardon reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT gokcetopal reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT mariepaulejacob reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT danlongrois reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
AT xaviernorel reverseregulatorypathwayh2spge2mmpinhumanaorticaneurysmandsaphenousveinvaricosity
_version_ 1716813435312799744